At this time, posts about Oscotec are rapidly increasing on portals and stock communities. Today, foreigners have sold a net 235,813 shares of Oscotec, and institutions have sold a net 6,000 shares, according to provisional data. Oscotec is known as a bio venture company developing new drugs related to bone tissue.
As of 1:30 PM on the 11th, Oscotec's stock price is 45,450 KRW, down 5.21% from the previous day, with a trading volume of 1,219,508 shares, which is 44.82% of the 5-day average trading volume. On January 8, Oscotec was an issue in the market due to the 'failure to prove the efficacy of "Sevidoplenib," leading to a weak performance.'
In addition to Oscotec, posts by investors are also rapidly increasing regarding Samchundang Pharmaceutical (000250), LG Electronics Preferred (066575), and Hyundai Glovis (086280).

※Source: AI Investment Assistant AI LACIRO
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
